Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ab1 (Biocytogen)
- Development stage
- Preclinical
- Lead developer
- Biocytogen
- Modality
- Antibody-Based Therapeutics
01
Overview
Ab1 (Biocytogen): sourced facts only. name: "Biocytogen developed a BsAb Ab1 that targets human CD3 and human HER2, and evaluated its efficacy and mechanism of action in preclinical studies." [DOI:10.1158/1538-7445.am2025-1279]; target: "Biocytogen developed a BsAb Ab1 that targets human CD3 and human HER2, and evaluated its efficacy and mechanism of action in preclinical studies." [DOI:10.1158/1538-7445.am2025-1279]; developer: "Biocytogen developed a BsAb Ab1 that targets human CD3 and human HER2, and evaluated its efficacy and mechanism of action in preclinical studies." [DOI:10.1158/1538-7445.am2025-1279]; modality: "Biocytogen developed a BsAb Ab1 that targets human CD3 and human HER2, and evaluated its efficacy and mechanism of action in preclinical studies." [DOI:10.1158/1538-7445.am2025-1279]; stage: "In a syngeneic transplantation model using B-hCD3E/hHER2 mice inoculated with the B-hHER2 MC38 plus cell line, BsAb Ab1 effectively inhibited tumor growth." [DOI:10.1158/1538-7445.am2025-1279]
02
Targets
ERBB2 (Erb-b2 receptor tyrosine kinase 2)
Beyond the preview
Go deeper on Ab1 (Biocytogen).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ab1 (Biocytogen).